Megaloblastic anemia in the course of Vinblastine sulphate (VELBE) therapy

Clicks: 162
ID: 260702
1970
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #36 of 99 articles by views in blut

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
A case of Hodgkin's disease who developed a megaloblastic anemia following treatment with Vinblastine sulfate is presented. The causal relationship is discussed. This case was also interesting for following reasons: 1. In this patient, Hodgkin's disease was heralded by pure red cell aplasia. 2. Phytohaemagglutinin was used for the treatment of pure red cell aplasia and for the correction of leukopenia which occured during nitrogen mustard therapy, with partial success in the former and complete success in the latter instances. In this patient, Hodgkin's disease was heralded by pure red cell aplasia. Phytohaemagglutinin was used for the treatment of pure red cell aplasia and for the correction of leukopenia which occured during nitrogen mustard therapy, with partial success in the former and complete success in the latter instances.
Reference Key
aksoy1970blutmegaloblastic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors M. Aksoy;S. Erdem;K. Dinçol;M. Aksoy;S. Erdem;K. Dinçol;
Journal blut
Year 1970
DOI
doi:10.1007/BF01633087
URL
https://link.springer.com/article/10.1007/BF01633087
Keywords
oncology hematology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.